The annual general meeting in NeoDynamics AB (publ) was held on 24 May 2022 at the company’s premises on Lejonvägen 14, Lidingö, whereby the shareholders primarily resolved on the following matters.
Annual report and result
The annual report and the auditor's report for the financial year 2021 were presented and the income statement and balance sheet included in the annual report were adopted.
It was resolved to not pay any dividends and that the company’s result shall be retained in the business.
Discharge from liability
The annual general meeting resolved to grant each of the members of the board of directors and the CEO discharge from liability in respect of the company for the financial year 2021.
It was resolved that remuneration shall be paid with SEK 200,000 to the chairman of the board, and with SEK 125,000 to each other member of the board.
It was further resolved that remuneration shall be paid to the auditor in accordance with approved invoice.
Board of directors
The annual general meeting resolved that the board shall consist of six ordinary members without deputy members.
It was resolved to reelect Carina Bolin, Claes Pettersson, Ingrid Salén, Jie Bao, Xiao-Jun Xu and Matthew E. Colpoys, Jr. as board members for the period until the end of the next annual general meeting. Ingrid Salén was reelected as chairman of the board.
The annual general meeting resolved that one auditor, without deputy auditors, shall be appointed.
It was resolved to reelect Margareta Kleberg, authorized public accountant at the auditing company BDO, as auditor for the period until the end of the next annual general meeting.
It was resolved to establish a nomination committee for the next annual general meeting, which is to be appointed according to the principles, and perform its work in accordance with the instructions proposed by the board of directors. It was resolved that the principles and instructions shall apply until further notice and until a new resolution on nomination committee is resolved by the annual general meeting.
For further information, please contact:
Anna Eriksrud, CEO NeoDynamics AB, phone +46 708 444 966 or e-mail firstname.lastname@example.org
Aaron Wong, CFO NeoDynamics AB (publ), phone +46 735 972 011 or e-mail email@example.com
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in UK, Germany, and Sweden. The pulse biopsy system has been used for tissue sampling in breast and axilla in over 500 patients.